Evidence map›Paper›PMID 41383173›Full record

ArticleEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin2025

Lessons from an investigation of an autochthonous chikungunya outbreak in Bergerac, mainland France, June to October 2025.

Roman Creuse, Alice Herteau, Anne Bernadou, Valérie Cesa, Karim Tararbit, Guillaume Lacour, Delphine Binet, Guillaume André Durand, Florian Franke, Catarina Krug and 1 more

Abstract read
In one paragraph

Article in Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Roman CreuseSanté publique France (French National Public Health Agency), Bordeaux, France.
Alice HerteauSanté publique France (French National Public Health Agency), Bordeaux, France.
Anne BernadouSanté publique France (French National Public Health Agency), Bordeaux, France.
Valérie CesaRegional Health Agency of Nouvelle-Aquitaine (ARS Nouvelle-Aquitaine), Périgueux, France.
Karim TararbitRegional Health Agency of Nouvelle-Aquitaine (ARS Nouvelle-Aquitaine), Bordeaux, France.
Guillaume LacourAltopictus, Saint-Jean-d'Illac, France.
Delphine BinetAltopictus, Saint-Jean-d'Illac, France.
Guillaume André DurandNational Reference Centre for Arboviruses (NRC), National Institute of Health and Medical Research (Inserm) and French Armed Forces Biomedical Research Institute (IRBA), Marseille, France.
Florian FrankeSanté publique France (French National Public Health Agency), Marseille, France.
Catarina KrugSanté publique France (French National Public Health Agency), Saint-Maurice, France.
Laurent FilleulSanté publique France (French National Public Health Agency), Bordeaux, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In 2025, an unprecedented number of autochthonous chikungunya transmission events occurred in mainland France. One of the largest outbreaks took place in Bergerac (south-west France). By 27 October, 100 locally acquired cases were identified. They had symptom onsets between June and October. Our data suggest that door-knocking surveys and vector control measures assisted in slowing the virus spread. Autochthonous outbreaks of mosquito-borne diseases are expected to become more frequent with climate change, so improving outbreak control is crucial.

Indexed as

AedesChikungunya FeverChikungunya virusDisease OutbreaksAdolescentAdultAgedAnimalsFemaleFranceHumansMaleMiddle AgedMosquito ControlMosquito VectorsYoung Adultchikungunyadoor-knocking surveylocal transmissionoutbreak

Identifiers

PMID41383173
PMCPMC12701331

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.